dr. daniel petrylak discusses chemotherapy in prostate cancer
Published 12 years ago • 446 plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
1:43
dr. petrylak discusses sequencing prostate cancer therapies
-
0:34
dr. petrylak discusses custirsen as a potential treatment for prostate cancer
-
0:47
dr. daniel petrylak describes the clinical investigation of prostvac in prostate cancer
-
1:03
dr. daniel petrylak on the role of enzalutamide in prostate cancer
-
1:21
dr. petrylak explains prostate cancer clinical trial difficulties
-
1:43
dr. petrylak on imaging approaches in prostate cancer
-
1:08
dr. daniel petrylak explains the correlation between immune response to sipuleucel-t and survival
-
0:47
dr. petrylak on the recent developments in prostate cancer
-
0:41
dr. daniel petrylak discusses the future of abiraterone acetate
-
7:59
factors impacting treatment approach in advanced prostate cancer
-
1:11
dr. daniel petrylak on orteronel (tak-700) plus docetaxel in prostate cancer
-
2:37
dr. daniel petrylak discusses novel bone targeted therapies in prostate cancer
-
1:47
dr. petrylak on sequencing of targeted agents in bladder cancer
-
8:12
asco gu 2020: dr. petrylak discusses exciting prostate cancer and bladder cancer data
-
1:18
dr. petrylak on the role of psa screening in prostate cancer
-
1:05
dr. petrylak on psma adc for patients with mcrpc
-
8:30
monitoring patients during treatment for advanced prostate cancer
-
1:55
dr. petrylak discusses psma-directed therapies in prostate cancer
-
3:30
repeat molecular testing in advanced prostate cancer